Literature DB >> 6475944

Membranoproliferative glomerulonephritis type I in children: correlation of clinical features with pathologic subtypes.

A R Watson, S Poucell, P Thorner, G S Arbus, C P Rance, R Baumal.   

Abstract

Renal biopsies from 33 patients with membranoproliferative glomerulonephritis (MPGN) type I were reviewed to identify pathologic subtypes of this disease and assess their correlation to clinical features. The patients were divided into two groups: group A included 16 patients in chronic or end-stage renal failure and group B 17 patients with no evidence of renal insufficiency. At presentation, a nephrotic or nephritic syndrome and azotemia were equally common in both groups. The incidence of hypertension was significantly increased in group A (P less than 0.05), while recurrent gross hematuria was more common in group B. Nephrotic syndrome was more common during the course of illness in group A. Three subtypes of MPGN type I were recognized, based on whether duplication of glomerular capillary basement membranes was focal segmental (FS; 9 cases), diffuse global (DG; 18 cases), or mixed segmental and global (6 cases). Eight of nine patients showing FS MPGN type I were in group B (p less than 0.05). In contrast, 11 of 18 patients with DG MPGN type I and 4 of 6 with a segmental and global pattern were in group A (P = not significant). Therefore, FS MPGN is a good predictor of a favorable clinical outcome, whereas the other two subtypes are not. This was confirmed by a 100% actuarial kidney survival for the nine patients with FS MPGN and a 50% kidney survival of 7.5 years for patients with the other two subtypes.

Entities:  

Mesh:

Year:  1984        PMID: 6475944     DOI: 10.1016/s0272-6386(84)80062-1

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

1.  Long-term follow-up of atypical membranoproliferative glomerulonephritis: are steroids indicated?

Authors:  Teruo Fujita; Kandai Nozu; Kazumoto Iijima; Ichiro Kamioka; Kunihiko Yoshiya; Ryojiro Tanaka; Kiyoshi Hamahira; Koichi Nakanishi; Norishige Yoshikawa; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2005-10-25       Impact factor: 3.714

2.  Long-term follow-up of diffuse membranoproliferative glomerulonephritis type I.

Authors:  Takeshi Yanagihara; Mari Hayakawa; Junko Yoshida; Masami Tsuchiya; Toshisada Morita; Mutsumi Murakami; Yoshitaka Fukunaga
Journal:  Pediatr Nephrol       Date:  2005-03-22       Impact factor: 3.714

3.  Focal segmental membranoproliferative glomerulonephritis in children.

Authors:  Kikuo Iitaka; Shinya Nakamura; Shunsuke Moriya; Osamu Motoyama; Tadasu Sakai
Journal:  Pediatr Nephrol       Date:  2003-07-23       Impact factor: 3.714

Review 4.  Idiopathic membranoproliferative glomerulonephritis in childhood.

Authors:  C D West
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

5.  Non-nephrotic children with membranoproliferative glomerulonephritis: are steroids indicated?

Authors:  M Somers; S Kertesz; S Rosen; J Herrin; R Colvin; N Palacios de Carreta; M Kim
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

6.  Idiopathic membranoproliferative glomerulonephritis in Japanese children.

Authors:  K Iitaka; T Ishidate; M Hojo; S Kuwao; N Kasai; T Sakai
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

7.  Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy.

Authors:  J M Bergstein; S P Andreoli
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

8.  Participation of CR1 (CD35), CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in membranoproliferative glomerulonephritis type I.

Authors:  J Soma; T Saito; J Seino; H Sato; T Ootaka; A Yusa; K Abe
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.